RNAi-mediated shRNA gene silencing allowed for depletion of BLM, which led to inhibition of specific osteosarcoma cells, implicating its potential use in osteosarcoma (Mao et al., 2010; Futami and Furuichi, 2014). This evidence concerns the gene BLM and osteosarcoma.